Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Revelol-CH 50/6.25 Tablet ER

Prescription Icon
Prescription Required

Marketer

Ipca Laboratories Ltd

Salt Composition

Metoprolol Succinate (50mg) + Chlorthalidone (6.25mg)

Overview Revelol-CH 50/6.25 Tablet ER

Cardioxyl-XR 50/6.25 extended-release tablets manage hypertension (high blood pressure). It's prescribed when a single medication proves insufficient. This treatment lowers the risk of future strokes and heart attacks; early use significantly improves heart attack survival rates. Take Cardioxyl-XR once daily, preferably in the morning, with or without food, to minimize nighttime urination. Continue as directed by your physician; don't discontinue even if feeling well, as hypertension is often asymptomatic. Stopping could worsen your condition. Lifestyle modifications, including regular exercise, weight management, and a healthy diet, complement this therapy. Always adhere to your doctor's instructions. Common side effects include nausea, constipation, diarrhea, and fatigue. Report any persistent, worsening, or bothersome side effects. Increase fluid intake to alleviate potential muscle weakness, dry mouth, or thirst. Initial dizziness or headaches, possibly due to lower blood pressure, usually subside. Inform your doctor of any kidney or liver issues before starting treatment. Pregnant or breastfeeding individuals should consult their physician. Disclose all current medications, particularly those for hypertension or heart conditions. Regular monitoring of blood pressure, kidney function, blood sugar, and electrolyte levels (potassium, magnesium) ensures optimal treatment efficacy.

Uses of Revelol-CH 50/6.25 Tablet ER

Elevated arterial blood pressure

Major Benefits of Revelol-CH 50/6.25 Tablet ER:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Revelol-CH 50/6.25 Extended-Release Tablets can be consumed with or without food, though consistent timing is recommended.

Common Side effects of Revelol-CH 50/6.25 Tablet ER:

  • Nausea
  • Constipation
  • Diarrhea
  • Fatigue
  • Headache
  • Dizziness
  • Slow heart rate
  • Increased blood uric acid
  • Decreased potassium level in blood
  • Glucose intolerance
  • Altered blood lipid level
  • Cold extremities
  • Decreased magnesium level in blood
  • Increased calcium level in blood

How to use Revelol-CH 50/6.25 Tablet ER:

Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing. Revelol-CH 50/6.25 Extended-Release Tablets can be consumed with or without food, however, consistent daily timing is recommended.

How Revelol-CH 50/6.25 Tablet ER works:

Revelol-CH 50/6.25 Extended-Release tablets combine metoprolol succinate, a beta-blocker, and chlorthalidone, a diuretic, to effectively manage hypertension. Metoprolol succinate acts on the heart, slowing the heart rate and enhancing its pumping efficiency. Chlorthalidone reduces blood pressure by eliminating excess fluid and electrolytes, while concurrently promoting vasodilation and improved circulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Revelol-CH 50/6.25 Tablet ER is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Revelol-CH 50/6.25 tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Revelol-CH 50/6.25 tablets are likely safe for breastfeeding mothers. Available human data indicates minimal infant risk associated with the medication.

DrivingDrivingUNSAFE

Taking Revelol-CH 50/6.25 Extended-Release tablets may cause drowsiness, blurred vision, or dizziness. Driving should be avoided if these side effects are experienced.

KidneyKidneyCAUTION

Exercise caution when prescribing Revelol-CH 50/6.25 Tablet ER to individuals with severely impaired renal function. Dosage modification may be necessary. Physician consultation is advised. This medication is contraindicated in patients with such conditions.

LiverLiverCAUTION

Patients with hepatic impairment should use Revelol-CH 50/6.25 Tablet ER cautiously, potentially requiring dosage modification. Physician consultation is advised. Revelol-CH 50/6.25 Tablet ER is contraindicated in patients exhibiting severe liver dysfunction.

What if you forget to take Revelol-CH 50/6.25 Tablet ER :

Should you forget a Revelol-CH 50/6.25 Tablet ER dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Revelol-CH 50/6.25 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Heart
Revelol-CH 50/6.25 Tablet...
119
MRP 137
13% off